Gary Doyle

Gary Doyle is an analytical chemistry subject matter expert at Gilead Sciences, where they review documentation to support NDA submissions. They have extensive experience in analytical development, including method development, validation, and implementation across various pharmaceutical products and biofuels. Prior to their current role, Gary worked at Dey Pharma L.P. and Amyris Inc., where they developed significant analytical methods and contributed to projects that improved product formulations and stability. Gary earned a B.S. in Chemistry from The University of Manchester.